Tango Therapeutics Company Profile

14:47 EDT 19th September 2019 | BioPortfolio

Tango Therapeutics is a biotechnology company developing novel medicines for patients by discovering and drugging context-dependent vulnerabilities in cancers. Tango was launched in 2017 by Third Rock Ventures and is headquartered in Cambridge, Mass. For more information, please visit

News Articles [923 Associated News Articles listed on BioPortfolio]

Accent Therapeutics Taps Tango’s Shakti Narayan for CEO

Shakti Narayan has joined Accent Therapeutics as CEO and member of the company’s board of directors. Narayan comes to Lexington, MA-based Accent from Tango Therapeutics, where he was chief business ...

UA College partners with Space Tango to develop an easy way to test astronauts' health in space

Researchers at the University of Arizona College of Medicine - Phoenix are partnering with Space Tango, a private aerospace company that designs, builds and operates facilities on the International Sp...

ViiV Healthcare announces positive week 48 results from TANGO study of dolutegravir/lamivudine

Full Week 48 findings were presented today at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City. Kimberly Smith, MD, Head of Global The post ViiV Healthcare anno...

Roche, Novartis, Ipsen, Amana, Tango and Redmed Group Recognized as Best Places to Work in Algeria in 2019

ALGIERS, Algeria, Feb. 18, 2019 /PRNewswire/ -- Roche, Novartis, Ipsen, Amana, Tango and Redmed group were recognized yesterday as the Best Places To Work in Algeria for 2019 according to the annu...

Tango Therapeutics Appoints Reid Huber, PhD, to Board of Directors

Leadership strengthened with appointment of Jannik N. Andersen, PhD, Head of Biology and Jeff Caravella, MBA, VP, Finance Tango Therapeutics, a biotechnology company committed to discovering and de...

Accent Therapeutics Appoints Shakti Narayan as Chief Executive Officer

Biopharmaceutical executive strengthens Accent’s leadership team with a strong record of success across the biotechnology and pharmaceutical industries Accent Therapeutics, a biopharmaceutical com...

ViiV Healthcare announces positive Week 48 results in first study to evaluate treatment switch from TAF-containing regimen with three or more drugs to 2-drug regimen of dolutegravir/lamivudine for HIV-1 infection

Data from the TANGO study presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) demonstrate non-inferior efficacy of Dovato▼ (dolutegravir/lamivudine) in virally sup...

Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference

Stoke Therapeutics will present next week at the Cowen and Company 39th Annual Health Care Conference in Boston on its work to develop the first gene-specific, disease-modifying t...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]


Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [452 Associated PubMed Articles listed on BioPortfolio]

A Randomized Controlled Trial to Investigate the Impact of Tango Argentino versus Tai Chi on Quality of Life in Patients with Parkinson Disease: A Short Report.

Parkinson disease (PD) is a neurodegenerative disorder with increasing impairments in disease progression. The aim of the pilot study was to investigate the influence of Tango argentino on the quality...

Crossveinless is a direct transcriptional target of Trachealess and Tango in Drosophila tracheal precursor cells.

Understanding the transcriptional pathways controlling tissue-specific gene expression is critical to unraveling the complex regulatory networks that underlie developmental mechanisms. Here, we assess...

Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.

Intracellular signal transduced by G protein-coupled receptors (GPCRs) is tightly controlled by a guanine nucleotide-binding complex made of G protein Gα, Gβ, and Gγ subunits, as well as a growing ...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Clinical Trials [191 Associated Clinical Trials listed on BioPortfolio]

Inflammatory Arthritis and Tango

The hypothesis is that pleasure brought by argentine tango practice would increase total physical activity of patients with chronic inflammatory arthritis.

Tango for Alzheimer's Disease Patients' Caregivers

The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condi...

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [1371 Associated Companies listed on BioPortfolio]

Tango Therapeutics

Tango Therapeutics is a biotechnology company developing novel medicines for patients by discovering and drugging context-dependent vulnerabilities in cancers. Tango was launched ...

Tango Health, Inc.

Tango Health, Inc. provides innovative web-based services to support consumer-directed health care. The company’s web-based Health Savings Account (HSA) management platform h...

DanceSport California

DanceSport California (DanceSport CA) specializes in dance instruction of Salsa, Mambo, Cha-Cha-Cha, West Coast Swing, Lindy Hop, Bachata and Argentine Tango. Their dance programs cater to adults by ...

Grand Boulevand Hotel

Our Hotel rises on 9 de Julio Avenue, one of the widest avenues in the world due to its typical central boulevard, a few steps away from the most emblematic symbol of Buenos Aires: the Obelisk (“Obe...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Tango Therapeutics" on BioPortfolio

We have published hundreds of Tango Therapeutics news stories on BioPortfolio along with dozens of Tango Therapeutics Clinical Trials and PubMed Articles about Tango Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tango Therapeutics Companies in our database. You can also find out about relevant Tango Therapeutics Drugs and Medications on this site too.

Quick Search

Relevant Topic

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Corporate Database Quicklinks

Searches Linking to this Company Record